Uncertainty remains over FDA block on China engineering of US cells
The FDA has announced it will no longer accept clinical trials that involve sending cells from US to China for gene editing.
21 August 2025
21 August 2025
The FDA has announced it will no longer accept clinical trials that involve sending cells from US to China for gene editing.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.